{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:32:20Z","timestamp":1791923540226,"version":"4.3.4"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Antenatal corticosteroids (ACS) are routinely administered to women at risk of preterm delivery to improve neonatal respiratory outcomes. However, ACS exposure has been associated with neonatal hypoglycemia, and its impact on overall glycemic control and variability\u2014particularly at earlier gestational ages\u2014remains incompletely defined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To evaluate glycemic control using continuous glucose monitoring (CGM) in preterm infants exposed to ACS and to assess the influence of timing of administration and gestational age on glycemic patterns.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This prospective single-center cohort study included preterm infants born at &amp;lt;35 weeks of gestation and admitted to a level III neonatal intensive care unit between February 2023 and August 2024. Infants were classified according to ACS exposure as complete course, partial course, or no exposure. CGM was performed during the first 48 hours of life. Hypoglycemic (&amp;lt;45 mg\/dL) and hyperglycemic (&amp;gt;180 mg\/dL) events, as well as glycemic variability assessed by the mean amplitude of glycemic excursions (MAGE), were analyzed. Subgroup analyses were conducted based on the interval between ACS administration and delivery (\u22647 days vs &amp;gt;7 days) and gestational age (&amp;lt;34 vs \u226534 weeks). Statistical significance was adjusted using the Benjamini\u2013Hochberg procedure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Sixty-four infants were included (41 complete ACS, 15 partial ACS, 8 no ACS). Baseline characteristics were comparable among groups. During the first day of life, hypoglycemic events occurred exclusively in infants exposed to a complete course of ACS (p = 0.005), predominantly in those exposed within seven days prior to delivery. This difference was not observed on the second day. Hyperglycemic events were significantly more frequent in infants born before 34 weeks of gestation (p = 0.005). Glycemic variability, assessed by MAGE, did not differ significantly according to ACS exposure, timing, or gestational age.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Exposure to a complete and recent course of ACS is associated with an increased risk of early neonatal hypoglycemia in preterm infants, particularly within the first 24 hours of life. CGM enables detailed assessment of glycemic instability and may support improved metabolic monitoring in this high-risk population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1847988","type":"journal-article","created":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:42:01Z","timestamp":1790916121000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of antenatal corticosteroid exposure on glycemic control in preterm infants assessed by continuous glucose monitoring: preliminary results from a single center study"],"prefix":"10.3389","volume":"17","author":[{"given":"Irene","family":"Bonato","sequence":"first","affiliation":[{"name":"Neonatal Intensive Care Unit, Department of Maternal and Neonatal Health, IRCCS Istituto Giannina Gaslini","place":["Genoa, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Calandrino","sequence":"additional","affiliation":[{"name":"Neonatal Intensive Care Unit, Department of Maternal and Neonatal Health, IRCCS Istituto Giannina Gaslini","place":["Genoa, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuele","family":"Caruggi","sequence":"additional","affiliation":[{"name":"Neonatal Intensive Care Unit, Department of Maternal and Neonatal Health, IRCCS Istituto Giannina Gaslini","place":["Genoa, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcella","family":"Battaglini","sequence":"additional","affiliation":[{"name":"Neonatal Intensive Care Unit, Department of Maternal and Neonatal Health, IRCCS Istituto Giannina Gaslini","place":["Genoa, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Vinci","sequence":"additional","affiliation":[{"name":"Neonatal Intensive Care Unit, Department of Maternal and Neonatal Health, IRCCS Istituto Giannina Gaslini","place":["Genoa, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaia","family":"Cipresso","sequence":"additional","affiliation":[{"name":"Neonatal Intensive Care Unit, Department of Maternal and Neonatal Health, IRCCS Istituto Giannina Gaslini","place":["Genoa, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Montobbio","sequence":"additional","affiliation":[{"name":"Neonatal Intensive Care Unit, Department of Maternal and Neonatal Health, IRCCS Istituto Giannina Gaslini","place":["Genoa, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Andreato","sequence":"additional","affiliation":[{"name":"Neonatal Intensive Care Unit, Department of Maternal and Neonatal Health, IRCCS Istituto Giannina Gaslini","place":["Genoa, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Brigati","sequence":"additional","affiliation":[{"name":"Neonatal Intensive Care Unit, Department of Maternal and Neonatal Health, IRCCS Istituto Giannina Gaslini","place":["Genoa, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca Antonio","family":"Ramenghi","sequence":"additional","affiliation":[{"name":"Neonatal Intensive Care Unit, Department of Maternal and Neonatal Health, IRCCS Istituto Giannina Gaslini","place":["Genoa, Italy"]},{"name":"Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Mother and Child Health, School of Medical and Pharmaceuticals, University of Genoa","place":["Genoa, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000002237","article-title":"Committee opinion no. 713: Antenatal corticosteroid therapy for fetal maturation","volume":"130","year":"2017","journal-title":"Obstetr Gynecol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1516783","article-title":"Antenatal betamethasone for women at risk for late preterm delivery","volume":"374","author":"Gyamfi-Bannerman","year":"2016","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/s41372-021-01162-y","article-title":"Respiratory and glycemic control outcomes of late preterm infants after antenatal corticosteroid exposure","volume":"41","author":"Janssen","year":"2021","journal-title":"J Perinatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1055\/a-2183-5062","article-title":"Neonatal hypoglycemia following late preterm antenatal corticosteroid administration in individuals with diabetes in pregnancy","volume":"41","author":"Raj-Derouin","year":"2024","journal-title":"Am J Perinatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3109\/14767058.2013.832750","article-title":"The association of antenatal corticosteroids with neonatal hypoglycemia and hyperbilirubinemia","volume":"27","author":"Pettit","year":"2014","journal-title":"J Maternal-Fetal Neonatal Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.earlhumdev.2020.104984","article-title":"Determinants of neonatal hypoglycemia after antenatal administration of corticosteroids (ACS) for lung maturation: Data from two referral centers and review of the literature","volume":"143","author":"di Pasquo","year":"2020","journal-title":"Early Hum Dev"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.634305","article-title":"Neonatal hypoglycemia and brain vulnerability","author":"De Angelis","year":"2021","journal-title":"Front Endocrinol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2017.1579","article-title":"Association of neonatal glycemia with neurodevelopmental outcomes at 4.5 years","volume":"171","author":"McKinlay","year":"2017","journal-title":"JAMA Pediatr"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1159\/000492859","article-title":"Neonatal glycaemia and neurodevelopmental outcomes: A systematic review and meta-analysis","volume":"115","author":"Shah","year":"2019","journal-title":"Neonatology"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2019.1566313","article-title":"Glycemic variability in continuous glucose monitoring negatively correlates with gestational age in very low birth weight infants","volume":"33","author":"Szymo\u0144ska","year":"2020","journal-title":"J Maternal-Fetal Neonatal Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/2768365","article-title":"Oxidative stress related diseases in newborns","volume":"2016","author":"Ozsurekci","year":"2016","journal-title":"Oxid Med Cell Longev"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3390\/CHILDREN10071220","article-title":"Diagnosis and management of neonatal hypoglycemia: A comprehensive review of guidelines","volume":"10","author":"Giouleka","year":"2023","journal-title":"Children"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11101945","article-title":"Continuous glucose monitoring in preterm infants: The role of nutritional management in minimizing glycemic variability","volume":"11","author":"Musso","year":"2022","journal-title":"Antioxidants"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2018-314814","article-title":"Targeting glucose control in preterm infants: Pilot studies of continuous glucose monitoring","volume":"104","author":"Thomson","year":"2019","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"B15","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s00431-025-06082-z","article-title":"Exploring the long-term impacts of neonatal hypoglycemia to determine a safe threshold for glucose concentrations","volume":"184","author":"Garg","year":"","journal-title":"Eur J Pediatr"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/s41390-020-0827-4","article-title":"Continuous glucose monitoring profile during therapeutic hypothermia in encephalopathic infants with unfavorable outcome","volume":"88","author":"Montaldo","year":"2020","journal-title":"Pediatr Res"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000551062","article-title":"European consensus guidelines on the management of respiratory distress syndrome \u2013 2025","author":"Sweet","year":"2026","journal-title":"Neonatology"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2018.06.947","article-title":"ESPGHAN\/ESPEN\/ESPR\/CSPEN guidelines on pediatric parenteral nutrition: Carbohydrates","volume":"37","author":"Mesotten","year":"2018","journal-title":"Clin Nutr"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i5044","article-title":"Antenatal corticosteroids for maturity of term or near term fetuses: Systematic review and meta-analysis of randomized controlled trials","volume":"355","author":"Saccone","year":"2016","journal-title":"BMJ (Online)"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.1036565","article-title":"Effects of antenatal corticosteroids on neonatal blood glucose fluctuation in late-preterm infants","volume":"10","author":"Zhou","year":"2022","journal-title":"Front Pediatr"},{"key":"B21","doi-asserted-by":"publisher","first-page":"892","DOI":"10.3109\/14767058.2014.936002","article-title":"Neonatal hypoglycemia associated with the antenatal corticosteroids may be secondary to fetal adrenal suppression","volume":"28","author":"Aydin","year":"2015","journal-title":"J Maternal-Fetal Neonatal Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2025.114897","article-title":"Association of catecholamines with blood glucose and severity of illness in infants born preterm","volume":"289","author":"Hoermann","year":"2026","journal-title":"J Pediatr"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1177\/193229681100500408","article-title":"Characterizing blood glucose variability using new metrics with continuous glucose monitoring data","volume":"5","author":"Marling","year":"2011","journal-title":"J Diabetes Sci Technol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0803725","article-title":"Early insulin therapy in very-low-birth-weight infants","volume":"359","author":"Beardsall","year":"2008","journal-title":"N Engl J Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2006-0628","article-title":"Hyperglycemia is a risk factor for early death and morbidity in extremely low birth-weight infants","volume":"118","author":"Hays","year":"2006","journal-title":"Pediatrics"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e31820eee00","article-title":"ACOG Committee Opinion No. 475: antenatal corticosteroid therapy for fetal maturation","volume":"117","year":"2011","journal-title":"Obstet Gynecol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1097\/MOP.0000000000000592","article-title":"Neonatal hypoglycemia: Continuous glucose monitoring","volume":"30","author":"Shah","year":"2018","journal-title":"Curr Opin Pediatr"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1847988\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:42:12Z","timestamp":1790916132000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1847988\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,2]]},"references-count":27,"alternative-id":["10.3389\/fendo.2026.1847988"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1847988","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,2]]},"article-number":"1847988"}}